European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)Mical Paul, Jesús Rodríguez‐Baño, Elena Carrara et al.|Clinical Microbiology and Infection|2021Cited by 1k
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort studyBelén Gutiérrez‐Gutiérrez, Mario Fernández‐Ruiz, Emmanuel Roilides et al.|The Lancet Infectious Diseases|2017Cited by 521
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>Mario Tumbarello, Pierluigi Viale, Enrico Maria Trecarichi et al.|Clinical Infectious Diseases|2018Cited by 351
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter StudyMario Tumbarello, Pierluigi Viale, Francesca Raffaelli et al.|Clinical Infectious Diseases|2021Cited by 264
Preventive and therapeutic strategies in critically ill patients with highly resistant bacteriaMatteo Bassetti, Garyphallia Poulakou, Jan J. De Waele et al.|Intensive Care Medicine|2015Cited by 182